ADAM17 and neurodegenerative disease: Given the pivotal role of ADAM17 in chronic inflammation, ADAM17 appears to be an attractive treatment target to delay or prevent low-grade chronic neuroinflammation and is associated with the pathophysiology of a number of neurodegenerative diseases.